Ma­rie-​Thérèse Fors­ter

Dr. Ma­rie-​Thérèse Fors­ter

orcid

Research Focus & Metrics

Academic Career Length

17Years (2010-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 May 2011 in Neurosurgery
Verified
Journal Article
Closed access
MFMa­rie-​Thérèse Fors­ter
Ma­rie-​Thérèse Fors­ter
EHElke Hattingen
Elke Hattingen
CSChristian Senft
Christian Senft
TGThomas Gasser
Thomas Gasser
VSVolker Seifert
Volker Seifert
ASAndrea Szelényi
Andrea Szelényi
Tumor resection in the vicinity of the motor cortex poses a challenge to all neurosurgeons. For preoperative assessment of eloquent cortical areas, functional magnetic resonance imaging (fMRI) is used, whereas intraoperatively, direct cortical stimulation (DCS) is performed. Navigated transcranial magnetic stimulation (nTMS) is comparable to DCS in activating cortical pyramidal neurons. To evaluate the reliability of nTMS compared with fMRI and DCS for preoperative resection planning of centrally located tumors. In a prospective series, 11 patients (ages, 20-63 years; mean, 41.9 ± 14.9 years, 2 women) with tumors located in or adjacent to the motor cortex were evaluated for surgery. fMRI and nTMS were applied for preoperative assessment of the extent of tumor resection. A 3-dimensional anatomic data set with superimposed fMRI data was integrated in the eXimia Navigated Brain Stimulation station for ensuing motor cortex mapping by nTMS. Responses from nTMS were evaluated by electromyographic response. During surgery, the coordinates of each DCS site were unambiguously defined and integrated into neuronavigation. A post hoc comparison of the coordinates of nTMS, fMRI, and DCS was performed. Distances from nTMS to DCS (10.5 ± 5.67 mm) were significantly smaller than those from fMRI to DCS (15.0 ± 7.6 mm). nTMS anticipates information usually only enabled by DCS and therefore allows surgical planning in eloquent cortex surgery.

1 August 2010 in Journal of Clinical Neuroscience
Verified
Journal Article
Closed access
MFMa­rie-​Thérèse Fors­ter
Ma­rie-​Thérèse Fors­ter
AMA.K. Mathé
A.K. Mathé
CSC. Senft
C. Senft
ISI. Scharrer
I. Scharrer
VSV. Seifert
V. Seifert
RGR. Gerlach
R. Gerlach

22 July 2022 in Neuro-Oncology
Verified
Journal Article
Closed access
PDF file
RDRichard Drexler
Richard Drexler
USUlrich Schüller
Ulrich Schüller
AEAlicia Eckhardt
Alicia Eckhardt
KFKatharina Filipski
Katharina Filipski
THTabea I Hartung
Tabea I Hartung
FRFranz Ricklefs
Franz Ricklefs
DNA methylation-based tumor classification allows an enhanced distinction into subgroups of glioblastoma. However, the clinical benefit of DNA methylation-based stratification of glioblastomas remains inconclusive. Multicentric cohort study including 430 patients with newly diagnosed glioblastoma subjected to global DNA methylation profiling. Outcome measures included overall survival (OS), progression-free survival (PFS), prognostic relevance of EOR and MGMT promoter methylation status as well as a surgical benefit for recurrent glioblastoma. 345 patients (80.2%) fulfilled the inclusion criteria and 305 patients received combined adjuvant therapy. DNA methylation subclasses RTK I, RTK II, and mesenchymal (MES) revealed no significant survival differences (RTK I: Ref.; RTK II: HR 0.9 [95% CI, 0.64–1.28]; p = 0.56; MES: 0.69 [0.47–1.02]; p = 0.06). Patients with RTK I (GTR/near GTR: Ref.; PR: HR 2.87 [95% CI, 1.36–6.08]; p < 0.01) or RTK II (GTR/near GTR: Ref.; PR: HR 5.09 [95% CI, 2.80–9.26]; p < 0.01) tumors who underwent gross-total resection (GTR) or near GTR had a longer OS and PFS than partially resected patients. The MES subclass showed no survival benefit for a maximized EOR (GTR/near GTR: Ref.; PR: HR 1.45 [95% CI, 0.68–3.09]; p = 0.33). Therapy response predictive value of MGMT promoter methylation was evident for RTK I (HR 0.37 [95% CI, 0.19–0.71]; p < 0.01) and RTK II (HR 0.56 [95% CI, 0.34–0.91]; p = 0.02) but not the MES subclass (HR 0.52 [95% CI, 0.27–1.02]; p = 0.06). For local recurrence (n = 112), re-resection conveyed a progression-to-overall survival (POS) benefit (p < 0.01), which was evident in RTK I (p = 0.03) and RTK II (p < 0.01) tumors, but not in MES tumors (p = 0.33). We demonstrate a survival benefit from maximized EOR for newly diagnosed and recurrent glioblastomas of the RTK I and RTK II but not the MES subclass. Hence, it needs to be debated whether the MES subclass should be treated with maximal surgical resection, especially when located in eloquent areas and at time of recurrence.

1 July 2012 in Spine
Verified
Journal Article
Closed access
MFMa­rie-​Thérèse Fors­ter
Ma­rie-​Thérèse Fors­ter
GMGerhard Marquardt
Gerhard Marquardt
VSVolker Seifert
Volker Seifert
ASAndrea Szelényi
Andrea Szelényi
A retrospective clinical analysis of patients operated on for spinal tumors. To report on the importance of intraoperative neurophysiological monitoring (INM) throughout the entire surgical procedure. Postoperative neurological deterioration, despite unaltered neurophysiological monitoring, has been reported. This might be related to timely restricted monitoring. Thus, the likelihood of alterations in INM from positioning to wound closure was analyzed. Two hundred three patients (age range, 54.9 ± 17.4 yr) undergoing intradural tumor removal were sampled in a prospective database and analyzed for the occurrence of alterations in intraoperative somatosensory- and motor-evoked potentials. INM alterations were observed in 47 of 203 (23.2%) patients. These alterations were related to tumor resection in 29 (14.3%) cases, whereas these were unrelated to tumor removal in 18 patients: laminotomy in 5 (2.5%) patients, dura opening in 7 (3.5%) patients, dura closure in 5 (2.5%) patients, and laminoplasty in 1 (0.5%) patient caused INM changes. This study demonstrates that monitoring beyond tumor resection is of essential importance in order to detect all critical phases of surgical procedure and to counteract accordingly.

7 June 2012 in Acta Neurochirurgica
Verified
Journal Article
Closed access
PDF file
MFMa­rie-​Thérèse Fors­ter
Ma­rie-​Thérèse Fors­ter
CSChristian Senft
Christian Senft
EHElke Hattingen
Elke Hattingen
MLMario Lorei
Mario Lorei
VSVolker Seifert
Volker Seifert
ASAndrea Szelényi
Andrea Szelényi

1 April 2022 in Journal of Neurosurgery
Verified
Journal Article
Closed access
PDF file
MFMa­rie-​Thérèse Fors­ter
Ma­rie-​Thérèse Fors­ter
MBMarion Behrens
Marion Behrens
AMAnna Cecilia Lawson McLean
Anna Cecilia Lawson McLean
DNDorothea Isabella Nistor-Gallo
Dorothea Isabella Nistor-Gallo
MWMiriam Weiss
Miriam Weiss
SMStefanie Maurer
Stefanie Maurer
OBJECTIVE: Despite the rising number of women in higher education and leadership positions, the proportional rise of female neurosurgeons still lags behind these fields. This study evaluates the gender distribution in German neurosurgical departments across all career levels, and is aimed at heightening the awareness of gender disparity and the need for improving gender equality and its related opportunities. METHODS: Data on gender distribution across all professional levels in German neurosurgical departments were obtained from departmental websites as well as by email and telephone request. Results were additionally analyzed in reference to hospital ownership type of the neurosurgical departments. RESULTS: A total of 140 German neurosurgical departments employing 2324 neurosurgeons were evaluated. The analysis revealed a clear preponderance of men in leadership positions. Only 9 (6.3%) of 143 department heads were women, and there were only 1 (2.4%), 17 (14.5%), and 4 (12.5%) women among 42 vice-directors, 117 chief senior physicians, and 32 managing senior physicians, respectively. Senior physicians not holding a leadership position were female in 23.1%, whereas board-certified neurosurgeons not holding a senior physician position and residents were female in 33.6% and 35.0%, respectively. Of note, the highest proportion of female department heads (15.6%) was found in private hospitals. CONCLUSIONS: The number of women in leadership positions in German neurosurgical departments is dramatically low, and with increasing leadership status gender disparity increases. Mentorship, recruitment, the perception of benefits offered by diversity and programs facilitating gender equality, job sharing, parental leave policies, and onsite childcare programs are needed to turn German neurosurgical departments into modern medical departments reflecting the gender profile of the general patient population.